Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.8282
-0.0007 (-0.08%)
At close: May 19, 2026, 4:00 PM EDT
0.8120
-0.0162 (-1.96%)
After-hours: May 19, 2026, 5:10 PM EDT
Citius Oncology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Citius Oncology stock has a target of 4.00, which predicts a 382.98% increase from the current stock price of 0.83.
Price Target: $4.00 (+382.98%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 23, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Citius Oncology is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $6 | Hold → Strong Buy | Upgrades | $6 | +624.46% | Sep 23, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 23, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +262.23% | Nov 27, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +624.46% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
39.65M
Revenue Next Year
121.32M
from 39.65M
Increased by 205.99%
EPS This Year
-0.19
from -0.34
EPS Next Year
0.40
from -0.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.8M | 124.9M | |
| Avg | 39.6M | 121.3M | |
| Low | 38.1M | 116.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 215.0% | |
| Avg | - | 206.0% | |
| Low | - | 194.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.20 | 0.41 | |
| Avg | -0.19 | 0.40 | |
| Low | -0.19 | 0.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.